Corrigendum
In the Journal of Asthma 2010; 47: 1106–1115 for the article “Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma,” the authors have noticed an error since publication. In the section Plasma Cortisol AUC0−24 h, the sentence that begins “Compared with the baseline values … ” should indicate that the nonsignificant reduction refers to MF/F 200/10 rather than FP/S 250/50 in order to coincide with the data presented in the figure. The sentence should read as follows:
“Compared with the baseline values, there were sustained statistically significant reductions in plasma cortisol AUC0−24 h in all treatment groups (p ≤ .043) at weeks 26 and 52, with the exception of a nonsignificant reduction for MF/F 200/10 μg at week 52 (p = .076).”
The authors apologize for this error.